vs
Healthpeak Properties(DOC)与KRONOS WORLDWIDE INC(KRO)财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是KRONOS WORLDWIDE INC的1.7倍($719.4M vs $418.3M),Healthpeak Properties净利率更高(73.2% vs -19.8%,领先93.0%),Healthpeak Properties同比增速更快(3.1% vs -1.1%),Healthpeak Properties自由现金流更多($357.0M vs $81.9M),过去两年Healthpeak Properties的营收复合增速更高(8.9% vs -6.5%)
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
克罗诺斯全球(原克罗诺斯公司)是一家美国跨国企业,总部位于美国马萨诸塞州洛厄尔,专注于提供劳动力管理与人力资本管理云服务,在全球拥有超过6000名员工,是该领域知名的服务提供商。
DOC vs KRO — 直观对比
营收规模更大
DOC
是对方的1.7倍
$418.3M
营收增速更快
DOC
高出4.2%
-1.1%
净利率更高
DOC
高出93.0%
-19.8%
自由现金流更多
DOC
多$275.1M
$81.9M
两年增速更快
DOC
近两年复合增速
-6.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $719.4M | $418.3M |
| 净利润 | $114.0M | $-82.8M |
| 毛利率 | — | -0.9% |
| 营业利润率 | 17.4% | -15.1% |
| 净利率 | 73.2% | -19.8% |
| 营收同比 | 3.1% | -1.1% |
| 净利润同比 | 2406.4% | -527.3% |
| 每股收益(稀释后) | $0.16 | $-0.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DOC
KRO
| Q4 25 | $719.4M | $418.3M | ||
| Q3 25 | $705.9M | $456.9M | ||
| Q2 25 | $694.3M | $494.4M | ||
| Q1 25 | $702.9M | $489.8M | ||
| Q4 24 | $698.0M | $423.1M | ||
| Q3 24 | $700.4M | $484.7M | ||
| Q2 24 | $695.5M | $500.5M | ||
| Q1 24 | $606.6M | $478.8M |
净利润
DOC
KRO
| Q4 25 | $114.0M | $-82.8M | ||
| Q3 25 | $-117.1M | $-37.0M | ||
| Q2 25 | $31.7M | $-9.2M | ||
| Q1 25 | $42.8M | $18.1M | ||
| Q4 24 | $4.5M | $-13.2M | ||
| Q3 24 | $85.9M | $71.8M | ||
| Q2 24 | $146.0M | $19.5M | ||
| Q1 24 | $6.7M | $8.1M |
毛利率
DOC
KRO
| Q4 25 | — | -0.9% | ||
| Q3 25 | 58.6% | 10.3% | ||
| Q2 25 | 60.2% | 12.7% | ||
| Q1 25 | 61.1% | 21.8% | ||
| Q4 24 | 60.3% | 20.4% | ||
| Q3 24 | 60.0% | 20.9% | ||
| Q2 24 | 60.6% | 20.0% | ||
| Q1 24 | 59.8% | 14.9% |
营业利润率
DOC
KRO
| Q4 25 | 17.4% | -15.1% | ||
| Q3 25 | 9.2% | -4.2% | ||
| Q2 25 | 5.7% | 1.5% | ||
| Q1 25 | 7.7% | 7.8% | ||
| Q4 24 | -2.2% | 6.8% | ||
| Q3 24 | 14.1% | 8.0% | ||
| Q2 24 | 22.3% | 7.2% | ||
| Q1 24 | 3.7% | 4.1% |
净利率
DOC
KRO
| Q4 25 | 73.2% | -19.8% | ||
| Q3 25 | -16.6% | -8.1% | ||
| Q2 25 | 4.6% | -1.9% | ||
| Q1 25 | 6.1% | 3.7% | ||
| Q4 24 | 0.7% | -3.1% | ||
| Q3 24 | 12.3% | 14.8% | ||
| Q2 24 | 21.0% | 3.9% | ||
| Q1 24 | 1.1% | 1.7% |
每股收益(稀释后)
DOC
KRO
| Q4 25 | $0.16 | $-0.72 | ||
| Q3 25 | $-0.17 | $-0.32 | ||
| Q2 25 | $0.05 | $-0.08 | ||
| Q1 25 | $0.06 | $0.16 | ||
| Q4 24 | $0.02 | $-0.11 | ||
| Q3 24 | $0.12 | $0.62 | ||
| Q2 24 | $0.21 | $0.17 | ||
| Q1 24 | $0.01 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $33.2M |
| 总债务越低越好 | $9.8B | $557.4M |
| 股东权益账面价值 | $7.5B | $751.1M |
| 总资产 | $20.3B | $1.8B |
| 负债/权益比越低杠杆越低 | 1.31× | 0.74× |
8季度趋势,按日历期对齐
现金及短期投资
DOC
KRO
| Q4 25 | $467.5M | $33.2M | ||
| Q3 25 | $91.0M | $27.7M | ||
| Q2 25 | $89.4M | $18.9M | ||
| Q1 25 | $70.6M | $20.5M | ||
| Q4 24 | $119.8M | $106.7M | ||
| Q3 24 | $180.4M | $94.8M | ||
| Q2 24 | $106.9M | $133.8M | ||
| Q1 24 | $101.8M | $120.7M |
总债务
DOC
KRO
| Q4 25 | $9.8B | $557.4M | ||
| Q3 25 | $9.1B | $626.2M | ||
| Q2 25 | $9.0B | $589.3M | ||
| Q1 25 | $8.9B | $557.2M | ||
| Q4 24 | $8.7B | $507.4M | ||
| Q3 24 | $8.6B | $554.3M | ||
| Q2 24 | $8.6B | $423.7M | ||
| Q1 24 | $8.8B | $426.9M |
股东权益
DOC
KRO
| Q4 25 | $7.5B | $751.1M | ||
| Q3 25 | $7.6B | $804.7M | ||
| Q2 25 | $7.9B | $846.8M | ||
| Q1 25 | $8.2B | $847.0M | ||
| Q4 24 | $8.4B | $817.0M | ||
| Q3 24 | $8.6B | $847.4M | ||
| Q2 24 | $8.8B | $774.6M | ||
| Q1 24 | $8.9B | $774.4M |
总资产
DOC
KRO
| Q4 25 | $20.3B | $1.8B | ||
| Q3 25 | $19.6B | $1.9B | ||
| Q2 25 | $19.8B | $1.9B | ||
| Q1 25 | $19.8B | $1.9B | ||
| Q4 24 | $19.9B | $1.9B | ||
| Q3 24 | $20.0B | $1.9B | ||
| Q2 24 | $20.2B | $1.7B | ||
| Q1 24 | $20.5B | $1.7B |
负债/权益比
DOC
KRO
| Q4 25 | 1.31× | 0.74× | ||
| Q3 25 | 1.20× | 0.78× | ||
| Q2 25 | 1.14× | 0.70× | ||
| Q1 25 | 1.08× | 0.66× | ||
| Q4 24 | 1.04× | 0.62× | ||
| Q3 24 | 1.00× | 0.65× | ||
| Q2 24 | 0.98× | 0.55× | ||
| Q1 24 | 0.99× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.3B | $92.1M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $81.9M |
| 自由现金流率自由现金流/营收 | 49.6% | 19.6% |
| 资本支出强度资本支出/营收 | 124.4% | 2.4% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $-40.4M |
8季度趋势,按日历期对齐
经营现金流
DOC
KRO
| Q4 25 | $1.3B | $92.1M | ||
| Q3 25 | $315.0M | $-7.9M | ||
| Q2 25 | $363.5M | $20.7M | ||
| Q1 25 | $279.4M | $-102.4M | ||
| Q4 24 | $1.1B | $49.3M | ||
| Q3 24 | $318.2M | $28.3M | ||
| Q2 24 | $316.2M | $38.2M | ||
| Q1 24 | $152.6M | $-43.3M |
自由现金流
DOC
KRO
| Q4 25 | $357.0M | $81.9M | ||
| Q3 25 | — | $-17.4M | ||
| Q2 25 | — | $9.5M | ||
| Q1 25 | — | $-114.4M | ||
| Q4 24 | $333.7M | $37.0M | ||
| Q3 24 | — | $19.2M | ||
| Q2 24 | — | $34.8M | ||
| Q1 24 | — | $-48.0M |
自由现金流率
DOC
KRO
| Q4 25 | 49.6% | 19.6% | ||
| Q3 25 | — | -3.8% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | -23.4% | ||
| Q4 24 | 47.8% | 8.7% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 7.0% | ||
| Q1 24 | — | -10.0% |
资本支出强度
DOC
KRO
| Q4 25 | 124.4% | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 105.6% | 2.9% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.0% |
现金转化率
DOC
KRO
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | — | ||
| Q1 25 | 6.52× | -5.66× | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | 0.39× | ||
| Q2 24 | 2.17× | 1.96× | ||
| Q1 24 | 22.85× | -5.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图